Adagio Medical Holdings, Inc. (ADGM) shareholders
Close on Nov 17, 2026Market cap $1.37MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Perceptive Advisors LLC Joint filing with Joseph Edelman (55.40%), Perceptive Life Sciences Master Fund, Ltd. (54.70%) | 15,321,655 | 55.40% | 13G (passive) amendment | Mar 31, 2026 |
| Joseph Edelman Joint filing with Perceptive Advisors LLC (57.50%), Perceptive Life Sciences Master Fund, Ltd. (56.80%) | 15,321,655 | 57.50% | 13G (passive) amendment | Dec 31, 2025 |
| Alyeska Fund GP, LLC Joint filing with Alyeska Investment Group, L.P. (9.90%), Anand Parekh (9.90%) | 2,096,784 | 9.90% | 13G (passive) | Dec 31, 2025 |
| Peter Kolchinsky Joint filing with RA Capital Management, L.P. (9.90%), Rajeev Shah (9.90%) and 1 more | 1,613,220 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Phillip Gross Joint filing with Adage Capital Management, L.P. (5.67%), Robert Atchinson (5.67%) | 1,258,501 | 5.67% | 13G (passive) amendment | Mar 31, 2026 |
| Daniel Schneeberger Joint filing with ADAR1 Capital Management, LLC (5.40%) | 1,205,447 | 5.40% | 13G (passive) amendment | Jun 30, 2026 |
| ADAR1 Capital Management, LLC Joint filing with Daniel Schneeberger (5.70%) | 1,205,447 | 5.70% | 13G (passive) | Dec 31, 2025 |
| Rajeev Shah Joint filing with RA Capital Management, L.P. (7.20%), Peter Kolchinsky (7.20%) and 1 more | 1,200,000 | 7.20% | 13G (passive) amendment | Jun 30, 2025 |
| RA Capital Management, L.P. Joint filing with Peter Kolchinsky (7.20%), Rajeev Shah (7.20%) and 1 more | 1,200,000 | 7.20% | 13G (passive) amendment | Mar 31, 2025 |
| Adage Capital Management, L.P. Joint filing with Robert Atchinson (6.88%), Phillip Gross (6.88%) | 1,058,501 | 6.88% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ADGM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 9,876,586 | 44.47% | $6.44M | +10 | 0.10% |
| Adage Capital Partners Gp, L.L.C. | 1,258,501 | 5.67% | $820.04K | – | 0.00% |
| ADAR1 Capital Management, LLC | 1,205,447 | 5.43% | $785.47K | – | 0.04% |
| Alyeska Investment Group, L.P. | 1,159,615 | 5.22% | $755.61K | – | 0.00% |
| Sio Capital Management, LLC | 698,989 | 3.15% | $455.46K | −589,472 | 0.08% |
| Silverarc Capital Management, LLC | 224,360 | 1.01% | $146.19K | −27,612 | 0.02% |
| Shaolin Capital Management LLC | 171,170 | 0.77% | $111.53K | – | 0.01% |
| Vanguard Capital Management LLC | 108,954 | 0.49% | $71.04K | +69,346 | 0.00% |
| Affinity Asset Advisors, LLC | 80,000 | 0.36% | $52.13K | – | 0.00% |
| Geode Capital Management, LLC | 79,115 | 0.36% | $51.55K | −46,126 | 0.00% |
| Vanguard Fiduciary Trust Co | 53,782 | 0.24% | $35.07K | – | 0.00% |
| Northern Trust Corp | 30,875 | 0.14% | $20.12K | +9,277 | 0.00% |
| Toronto Dominion Bank | 25,000 | 0.11% | $16.30K | – | 0.00% |
| Opaleye Management Inc. | 18,444 | 0.08% | $13.35K | – | 0.00% |
| XTX Topco Ltd | 18,153 | 0.08% | $11.83K | −5,197 | 0.00% |
| Citadel Advisors LLC | 16,155 | 0.07% | $10.53K | New | 0.00% |
| Hrt Financial LP | 13,705 | 0.06% | $8.00K | New | 0.00% |
| Citigroup Inc | 13,255 | 0.06% | $8.64K | +13,254 | 0.00% |
| Bank Of America Corp /De/ | 11,531 | 0.05% | $7.51K | −1,326 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,454 | 0.03% | $4.21K | +4,252 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 24 | 15M | 67.9% | 4 / 5 | 5 / 3 | 0M | 1M |
| Q1 2026 | 23 | 16M | 70.5% | 6 / 4 | 2 / 3 | 0M | 1M |
| Q4 2025 | 21 | 17M | 74.5% | 11 / 5 | 2 / 5 | 5M | 0M |
| Q3 2025 | 15 | 12M | 52.4% | 4 / 1 | 4 / 1 | 0M | 1M |
| Q2 2025 | 12 | 12M | 53.4% | 1 / 6 | 3 / 4 | 1M | 0M |
| Q1 2025 | 15 | 12M | 52.2% | 3 / 4 | 2 / 3 | 1M | 0M |
| Q4 2024 | 15 | 11M | 48.6% | 5 / 4 | 2 / 2 | 0M | 1M |
| Q3 2024 | 12 | 12M | 54.1% | 12 / 0 | 0 / 0 | 12M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held ADGM in Q2 2026, 57% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ADGM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 91,512 | 0.41% | $59.63K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 66,969 | 0.30% | $48.49K | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 17,442 | 0.08% | $11.37K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 10,400 | 0.05% | $7.53K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 5,436 | 0.02% | $3.94K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Todd Usen | Chief Executive Officer, Director | 207,315 | 0.93% | Mar 9, 2026 |
| Deborah Kaster | Chief Financial Officer | 15,000 | 0.07% | Mar 9, 2026 |
| Dan George | Interim CFO | – | – | Apr 28, 2025 |
| Keyvan Mirsaeedi-Farahani | Director | 12,770 | 0.06% | Oct 13, 2026 |
| Sandra A. Gardiner | Director | – | – | Aug 12, 2026 |
| Orly Mishan | Director | – | – | Aug 12, 2026 |
| Sean Salmon | Director | – | – | Aug 12, 2026 |
| James L. Cox | Director | 36,698 | 0.17% | Aug 12, 2026 |
| Timothy P. Moran | Director | – | – | Aug 12, 2026 |
| Advisors Llc Perceptive | Director, 10% owner | 9,876,586 | 44.47% | Oct 22, 2025 |
| Life Sciences LLC C2 | Director, 10% owner | – | – | Feb 14, 2025 |
| Life Sciences Master Fund Ltd Perceptive | 10% owner | – | – | Oct 22, 2025 |
| Joseph Edelman | 10% owner | – | – | Oct 22, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Deborah Kaster Chief Financial Officer | Dec 16, 2025 | Buy | +15,000 | $1.20 | $18.00K | 15,000 |
| Todd Usen Chief Executive Officer, Director | Dec 12, 2025 | Buy | +207,315 | $1.09 | $225.97K | 207,315 |
| Advisors Llc Perceptive Director, 10% owner | Jan 22, 2025 | Award | +64,167 | – | – | 9,675,684 |
| Keyvan Mirsaeedi-Farahani Director | Sep 27, 2024 | Other | +12,770 | – | – | 12,770 |
| Adam Leo Stone 10% owner | Sep 27, 2024 | Other | −3,501,600 | – | – | 0 |
| James L. Cox Director | Jul 31, 2024 | Other | +36,698 | – | – | 36,698 |
| Hakon Bergheim Chief Operating Officer | Jul 31, 2024 | Other | +7,539 | – | – | 7,539 |
| Olav Bergheim CEO, Director | Jul 31, 2024 | Other | +22,081 | – | – | 22,081 |
| Olav Bergheim CEO, Director | Jul 31, 2024 | Other | +212,053 | – | – | 212,053 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Adagio Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,802,007 shares on Sep 24, 2026 over the last 90 days.
See a number that looks wrong?